Seeing that "MACE can include both atherosclerotic events (MI and stroke) and CHF events," what's to prevent Hepalink from manufacturing Apabetalone in compliance with their licence agreement with Resverlogix?
Ref: https://agoracom.com/ir/Resverlogix/forums/discussion/topics/737203-meaning-of-mace-in-the-btd/messages/2258650#message
Koo